Evaluation of critical groups required for the binding of heparin to antithrombin.
about
Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)Mapping and quantification of the major oligosaccharide components of heparinStructural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cellsAnalysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.Ex vivo model of an immobilized-enzyme reactor.Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells.The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate.FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities.Sulfate metabolism in mycobacteria.New targets for glycosaminoglycans and glycosaminoglycans as novel targets.Biosynthesis of heparin and heparan sulfate.Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments.Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.Glycosaminoglycans and the regulation of blood coagulation.Interaction of heparin with synthetic antithrombin III peptide analogues.Control of growth factor networks by heparan sulfate proteoglycans.Determination of the pKa of glucuronic acid and the carboxy groups of heparin by 13C-nuclear-magnetic-resonance spectroscopyHeparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificitiesA major common trisulfated hexasaccharide core sequence, hexuronic acid(2-sulfate)-glucosamine(N-sulfate)-iduronic acid-N-acetylglucosamine-glucuronic acid-glucosamine(N-sulfate), isolated from the low sulfated irregular region of porcine intestinalIsolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: different mechanisms for heparin and sulfated galactans.Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies
P2860
Q24301292-42397ACF-A2D5-421C-A05C-493B6DA26588Q24528185-6AB5A972-A073-4510-BC6E-7DFF49B2881BQ28144354-C59AF2A5-9046-48F8-BC1B-D896BD576D25Q33648333-4C517DB2-EF70-434E-A10C-D6651BD69E91Q33673352-806D3164-E33B-4917-BC96-CF14FAA99CB6Q33852582-044D6F3B-1285-42E1-ABF7-D3F977F4657EQ33948367-D1EED08C-E857-4050-9C9D-E373C5BC8F62Q35056506-D3B5AC42-3D9A-4C8D-AA32-5A155C3B64F4Q36020898-7A19B609-C2D1-45EC-BD9E-31BCF6A0699EQ36577771-1BE0390B-21B9-475B-A793-4ECE34F46C72Q38081956-43DB120A-83D9-4935-8384-4E71639D5F34Q38254101-DD4E33C8-5A43-4AC9-9649-F4BED221C6D9Q38296443-441234E2-A7A6-4416-810D-298C430BE204Q38297068-0432D4DC-D26C-47D1-BA27-EA5D81C4A085Q38338348-B00EA1B6-26DE-487F-9B33-6EE36F910C6DQ38350614-10872047-CDA7-4767-A5AC-B2921BBEABBCQ40851193-96AB23D5-2233-44C4-8DE2-180099F2959EQ41763091-2337F336-9901-44AE-AC0D-D4276010F94AQ41962848-7C2BFBFD-9EF7-478E-A527-7E72C0FD28A9Q42034300-F7A244E1-663B-413E-B947-5916411EC7ABQ42276329-BA3B8CAE-E613-4809-ABFB-AA30666180BEQ42671353-126FA56C-D6F3-4888-8B4E-96150FD59EA9Q42970671-3396CFB9-FC6E-4824-9C25-BC5FCE0CDBD0Q44783973-E1A5E281-DC9B-4937-BEB8-94B9B9E501A5Q56895736-37AFADF8-13DD-4925-8A8E-5EAAF5E22E02
P2860
Evaluation of critical groups required for the binding of heparin to antithrombin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Evaluation of critical groups required for the binding of heparin to antithrombin.
@ast
Evaluation of critical groups required for the binding of heparin to antithrombin.
@en
type
label
Evaluation of critical groups required for the binding of heparin to antithrombin.
@ast
Evaluation of critical groups required for the binding of heparin to antithrombin.
@en
prefLabel
Evaluation of critical groups required for the binding of heparin to antithrombin.
@ast
Evaluation of critical groups required for the binding of heparin to antithrombin.
@en
P2093
P2860
P356
P1476
Evaluation of critical groups required for the binding of heparin to antithrombin.
@en
P2093
A W Stephens
R D Rosenberg
P2860
P304
P356
10.1073/PNAS.81.4.1030
P407
P577
1984-02-01T00:00:00Z